Sevion Therapeutics, Inc. (SVON) - Clean Technology - Deals and Alliances Profile

 Published On: Sep, 2015 |    No of Pages: 25 |  Published By: GlobalData | Format: PDF
Request Free Sample

Summary

Sevion Therapeutics, Inc. (Sevion), formerly known as Senesco Technologies, Inc is a cancer therapeutic company that discovers, develops and acquires innovative product candidates for the treatment of cancer and immunological diseases. The company’s offer products in autoimmune disease, oncology, diabetes, pain. It offers various pipelines such as Antibody Pipeline, Chimerasome Pipeline and Gene Regulation Pipeline. Sevion offers products and technologies in the areas of eIF5A, cancer, and inflammation. The company also concentrates on cancer, multiple myeloma (MM) and other B-cell cancers including mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL). Sevion is headquartered in San Diego, California, the US

Sevion Therapeutics, Inc. (SVON) - Clean Technology - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Clean Technology eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Sevion Therapeutics, Inc., Clean Technology, Deals By Year, 2009 to YTD 2015 5
Sevion Therapeutics, Inc., Clean Technology Deals By Type, 2009 to YTD 2015 6
Sevion Therapeutics, Inc., Clean Technology, Deals By Region, 2009 to YTD 2015 7
Sevion Therapeutics, Inc., Clean Technology, Deals By Sector, 2009 to YTD 2015 8
Sevion Therapeutics, Inc., Clean Technology, Deals Summary, 2009 to YTD 2015 9
Sevion Therapeutics, Inc., Clean Technology, Deal Details 10
Equity Offering 10
Senesco Technologies Completes Private Placement Of Shares For US$1.25 Million 10
Senesco Technologies Completes Second Tranche Of Private Placement For US$1.65 Million 12
Senesco Technologies Completes Private Placement Of US$11.5 Million 13
Senesco Technologies Completes Private Placement Of US$0.17 Million 15
Senesco Technologies Completes First Tranche Private Placement Of US$0.95 Million 17
Sevion Therapeutics, Inc. - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Feb 18, 2015: Sevion Therapeutics Reports Second Quarter 2015 Financial Results 21
Nov 17, 2014: Sevion Therapeutics Reports First Quarter 2015 Financial Results 22
Feb 18, 2014: Senesco Technologies Reports Second Quarter of Fiscal Year 2014 Financial Results 23
Strategy And Business Planning 24
Mar 12, 2014: Senesco Opens Two New Clinical Trial Sites and Initiates Treatment of the First Patient in South Africa 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables

Sevion Therapeutics, Inc., Clean Technology, Key Facts, 2014 1
Sevion Therapeutics, Inc., Clean Technology, Deals Summary, 2009 to YTD 2015 1
Sevion Therapeutics, Inc., Clean Technology, Deals By Year, 2009 to YTD 2015 5
Sevion Therapeutics, Inc., Clean Technology Deals By Type, 2009 to YTD 2015 6
Sevion Therapeutics, Inc., Clean Technology, Deals By Region, 2009 to YTD 2015 7
Sevion Therapeutics, Inc., Deals By Sector, 2009 to YTD 2015 8
Sevion Therapeutics, Inc., Clean Technology, Deals Summary, 2009 to YTD 2015 9
Senesco Technologies Completes Private Placement Of Shares For US$1.25 Million 10
Senesco Technologies Completes Second Tranche Of Private Placement For US$1.65 Million 12
Senesco Technologies Completes Private Placement Of US$11.5 Million 13
Senesco Technologies Completes Private Placement Of US$0.17 Million 15
Senesco Technologies Completes First Tranche Private Placement Of US$0.95 Million 17
Sevion Therapeutics, Inc., Key Competitors 18
Sevion Therapeutics, Inc., Key Employees 19
Sevion Therapeutics, Inc., Subsidiaries 20

List of Figures

Sevion Therapeutics, Inc., Clean Technology, Deals by Type, 2009 to YTD 2015 1
Sevion Therapeutics, Inc., Clean Technology, Deals By Year, 2009 to YTD 2015 1
Sevion Therapeutics, Inc., Clean Technology, Deals By Region, 2009 to YTD 2015 1
Sevion Therapeutics, Inc., Clean Technology, Deals By Sector, 2009 to YTD 2015 1
Sevion Therapeutics, Inc., Clean Technology, Deals By Year, 2009 to YTD 2015 5
Sevion Therapeutics, Inc., Clean Technology, Deals by Type, 2009 to YTD 2015 6
Sevion Therapeutics, Inc., Clean Technology, Deals By Region, 2009 to YTD 2015 7
Sevion Therapeutics, Inc., Clean Technology, Deals by Sector, 2009 to YTD 2015 8


If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.